Actively Recruiting
Study of Prucalopride in Breastfeeding Women with Chronic Idiopathic Constipation to Measure Drug Levels in Breast Milk and Monitor Infant Safety and Development
Led by Takeda · Updated on 2026-05-01
12
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying prucalopride, a medicine used to treat chronic idiopathic constipation CIC, in breastfeeding women. The study aims to measure how much prucalopride passes into breast milk and to monitor the growth, development, and possible side effects in the babies who are breastfed by mothers taking this medication. Participants must be women treated with prucalopride for functional constipation and breastfeeding their infants. Participants will provide one set of breast milk samples collected over 24 hours using an electric breast pump at home. These samples will be sent to the laboratory for analysis. The study observes participants who have been prescribed prucalopride tablets under medical supervision before joining and who continue breastfeeding during sample collection. During the babys first year, researchers will conduct telephone interviews every two months to ask questions about the baby and will ask participants to complete questionnaires assessing their infants growth and neurodevelopment. The study will measure prucalopride levels in milk at various times after dosing and track infant growth changes, developmental milestones, and any reported adverse effects up to one year of age.
CONDITIONS
Brief Title
A Study of Prucalopride in Breastfeeding Women With Constipation
Research Team
T
Takeda Contact
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here